Back to Ensign Peak Advisors, Inc Ensign Peak Advisors, Inc

DNLIDNLI
Showing 8 of 27 quarters

Position history for Ensign Peak Advisors, IncEnsign Peak Advisors, Inc's holdings in DENALI THERAPEUTICS INC

Ensign Peak Advisors, Inc holds 582,669 shares of DNLI (DENALI THERAPEUTICS INC), worth $15M as of 2026-Q2. The position was increased (+13.0% shares). DNLI represents 0.0% of Ensign Peak Advisors, Inc's portfolio.

Current Value

$15M

Current Shares

582,669

Total Value Change

+$4.9M

Total Shares Change

+236,365

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
582,669
+13.0%
$15M0.0%$25.72
32
2026-Q1
Unchanged
515,721
0.0%
$9.9M0.0%$20.02
0
2025-Q4
Decreased
515,721
-3.4%
$8.5M0.0%$16.41
0
2025-Q3
Increased
534,071
+12.8%
$7.8M0.0%$14.52
31
2025-Q2
Decreased
473,695
-19.4%
$6.6M0.0%$14.10
0
2025-Q1
Increased
587,785
+69.7%
$8M0.0%$14.78
41
2024-Q4
Unchanged
346,304
0.0%
$7.1M0.0%$20.24
0
2024-Q3
Unchanged
346,304
0.0%
$10.1M0.0%$29.43
0

Other major holders of DNLI: BAILLIE GIFFORD & CO, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used